Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancer
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-025-59588-3
Download full text from publisher
References listed on IDEAS
- Beth O. Van Emburgh & Sabrina Arena & Giulia Siravegna & Luca Lazzari & Giovanni Crisafulli & Giorgio Corti & Benedetta Mussolin & Federica Baldi & Michela Buscarino & Alice Bartolini & Emanuele Valto, 2016. "Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer," Nature Communications, Nature, vol. 7(1), pages 1-9, December.
- Andrea Bertotti & Eniko Papp & Siân Jones & Vilmos Adleff & Valsamo Anagnostou & Barbara Lupo & Mark Sausen & Jillian Phallen & Carolyn A. Hruban & Collin Tokheim & Noushin Niknafs & Monica Nesselbush, 2015. "The genomic landscape of response to EGFR blockade in colorectal cancer," Nature, Nature, vol. 526(7572), pages 263-267, October.
- Sandra Misale & Rona Yaeger & Sebastijan Hobor & Elisa Scala & Manickam Janakiraman & David Liska & Emanuele Valtorta & Roberta Schiavo & Michela Buscarino & Giulia Siravegna & Katia Bencardino & Andr, 2012. "Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer," Nature, Nature, vol. 486(7404), pages 532-536, June.
- Teklab Gebregiworgis & Yoshihito Kano & Jonathan St-Germain & Nikolina Radulovich & Molly L. Udaskin & Ahmet Mentes & Richard Huang & Betty P. K. Poon & Wenguang He & Ivette Valencia-Sama & Claire M. , 2021. "The Q61H mutation decouples KRAS from upstream regulation and renders cancer cells resistant to SHP2 inhibitors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
- Sharmistha Chakraborty & Li Li & Vineshkumar Thidil Puliyappadamba & Gao Guo & Kimmo J. Hatanpaa & Bruce Mickey & Rhonda F. Souza & Peggy Vo & Joachim Herz & Mei-Ru Chen & David A. Boothman & Tej K. P, 2014. "Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks," Nature Communications, Nature, vol. 5(1), pages 1-15, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Radia M. Johnson & Xueping Qu & Chu-Fang Lin & Ling-Yuh Huw & Avinashnarayan Venkatanarayan & Ethan Sokol & Fang-Shu Ou & Nnamdi Ihuegbu & Oliver A. Zill & Omar Kabbarah & Lisa Wang & Richard Bourgon , 2022. "ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Hui Deng & Qian Lei & Chengdi Wang & Zhoufeng Wang & Hai Chen & Gang Wang & Na Yang & Dan Huang & Quanwei Yu & Mengling Yao & Xue Xiao & Guonian Zhu & Cheng Cheng & Yangqian Li & Feng Li & Panwen Tian, 2022. "A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
- Dustin J. Flanagan & Raheleh Amirkhah & David F. Vincent & Nuray Gunduz & Pauline Gentaz & Patrizia Cammareri & Aoife J. McCooey & Amy M. B. McCorry & Natalie C. Fisher & Hayley L. Davis & Rachel A. R, 2022. "Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Yuan Yang & Ruizeng Luo & Shengyu Chao & Jiangtao Xue & Dongjie Jiang & Yun Hao Feng & Xin Dong Guo & Dan Luo & Jiaping Zhang & Zhou Li & Zhong Lin Wang, 2022. "Improved pharmacodynamics of epidermal growth factor via microneedles-based self-powered transcutaneous electrical stimulation," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
- Salvatore Siena & Kanwal Raghav & Toshiki Masuishi & Kensei Yamaguchi & Tomohiro Nishina & Elena Elez & Javier Rodriguez & Ian Chau & Maria Bartolomeo & Hisato Kawakami & Fumitaka Suto & Makito Koga &, 2024. "HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
- R. Sumanth Iyer & Sarah R. Needham & Ioannis Galdadas & Benjamin M. Davis & Selene K. Roberts & Rico C. H. Man & Laura C. Zanetti-Domingues & David T. Clarke & Gilbert O. Fruhwirth & Peter J. Parker &, 2024. "Drug-resistant EGFR mutations promote lung cancer by stabilizing interfaces in ligand-free kinase-active EGFR oligomers," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Umberto Perron & Elena Grassi & Aikaterini Chatzipli & Marco Viviani & Emre Karakoc & Lucia Trastulla & Lorenzo M. Brochier & Claudio Isella & Eugenia R. Zanella & Hagen Klett & Ivan Molineris & Julia, 2024. "Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
- Simonetta M. Leto & Elena Grassi & Marco Avolio & Valentina Vurchio & Francesca Cottino & Martina Ferri & Eugenia R. Zanella & Sofia Borgato & Giorgio Corti & Laura Blasio & Desiana Somale & Marianela, 2024. "XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
- Yan Li & Bing Wang & Wentao Yang & Fahan Ma & Jianling Zou & Kai Li & Subei Tan & Jinwen Feng & Yunzhi Wang & Zhaoyu Qin & Zhiyu Chen & Chen Ding, 2024. "Longitudinal plasma proteome profiling reveals the diversity of biomarkers for diagnosis and cetuximab therapy response of colorectal cancer," Nature Communications, Nature, vol. 15(1), pages 1-23, December.
- Hiroki Osumi & Eiji Shinozaki & Yoshiaki Nakamura & Taito Esaki & Hisateru Yasui & Hiroya Taniguchi & Hironaga Satake & Yu Sunakawa & Yoshito Komatsu & Yoshinori Kagawa & Tadamichi Denda & Manabu Shio, 2024. "Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
- Ke Gong & Gao Guo & Nicole A. Beckley & Xiaoyao Yang & Yue Zhang & David E. Gerber & John D. Minna & Sandeep Burma & Dawen Zhao & Esra A. Akbay & Amyn A. Habib, 2021. "Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids," Nature Communications, Nature, vol. 12(1), pages 1-17, December.
- Xinlei Zhuang & Zhe Wang & Jiansheng Fan & Xuefei Bai & Yingchun Xu & James J. Chou & Tingjun Hou & Shuqing Chen & Liqiang Pan, 2022. "Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59588-3. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.